Verantwoord innoveren

Synthetic biology
Adaptive Risk Assessment
GMO safety

A reported world-first in fertility therapy — a baby boy conceived using a controversial technique that mixes DNA from three people — has made headlines across the world. But with no way of verifying the claim because the specialists behind the procedure will not release data until October, some researchers are questioning the ethics of the procedure. In particular, they ask why the US-based team behind the operation chose to carry it out in Mexico, a country with less-clear oversight of human-embryo modification than, for instance, the United States.


Source: Nature, 29 September 2016.


​​ Kantoor:
+31 (0)343 51 47 61
+31 (0)6 238 68 017

Diederichslaan 25
3971 PA Driebergen